Hemispherian gets FDA green-light for glioblastoma trial of GLIX1
The U.S. Food and Drug Administration (FDA) will allow…
Glioma
Glioma overview
Gliomas are a group of brain tumors that arise from glial cells, a type of support cell of the central nervous system, or CNS, which comprises the brain and spinal cord. They make up about one-quarter of all tumors that start in the brain (primary brain tumors), occurring in about 6.6 per 100,000 people every year. They also account for more than 80% of all malignant, or cancerous, brain tumors.
Read moreGlioma treatment
Treatment for gliomas, a diverse group of tumors that form in the brain and spinal cord, can involve a variety of approaches, including surgery, radiation therapy, and chemotherapy, as well as a range of supportive treatments.
Read moreNews
Voranigo approval urged in EU for treatment of certain brain tumors
A committee of the European Medicines Agency (EMA) is…
Immune cells in blood may be glioma biomarkers: Study
A study found that analyzing levels of immune cells…
FDA names MB-101 US orphan drug for certain types of glioma
The U.S. Food and Drug Administration (FDA) has granted…
Stories being shared in honor of Glioblastoma Awareness Day
July 16 marks Glioblastoma Awareness Day (GBM Day), an…
GLIX1 named FDA orphan drug as potential malignant glioma therapy
The U.S. Food and Drug Administration (FDA) has granted…
